Calmark Sweden Past Earnings Performance
Past criteria checks 0/6
Calmark Sweden's earnings have been declining at an average annual rate of -39.3%, while the Medical Equipment industry saw earnings growing at 4.3% annually. Revenues have been declining at an average rate of 31.7% per year.
Key information
-39.3%
Earnings growth rate
-17.9%
EPS growth rate
Medical Equipment Industry Growth | 4.3% |
Revenue growth rate | -31.7% |
Return on equity | -54.1% |
Net Margin | -16,348.5% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Calmark Sweden makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 0 | -22 | 17 | 0 |
30 Sep 23 | 0 | -32 | 20 | 0 |
30 Jun 23 | 0 | -44 | 22 | 0 |
31 Mar 23 | 0 | -47 | 24 | 0 |
31 Dec 22 | 0 | -48 | 25 | 0 |
30 Sep 22 | 1 | -41 | 25 | 0 |
30 Jun 22 | 3 | -29 | 25 | 0 |
31 Mar 22 | 6 | -27 | 27 | 0 |
31 Dec 21 | 9 | -22 | 28 | 0 |
30 Sep 21 | 10 | -18 | 28 | 0 |
30 Jun 21 | 11 | -15 | 25 | 0 |
31 Mar 21 | 9 | -12 | 21 | 0 |
31 Dec 20 | 10 | -11 | 20 | 0 |
30 Sep 20 | 17 | -9 | 26 | 0 |
30 Jun 20 | 15 | -9 | 24 | 0 |
31 Mar 20 | 12 | -9 | 21 | 0 |
31 Dec 19 | 11 | -8 | 19 | 0 |
30 Sep 19 | 6 | -7 | 13 | 0 |
30 Jun 19 | 5 | -7 | 12 | 0 |
31 Mar 19 | 7 | -6 | 13 | 0 |
31 Dec 18 | 5 | -5 | 10 | 0 |
30 Sep 18 | 3 | -4 | 7 | 0 |
30 Jun 18 | 3 | -4 | 6 | 0 |
31 Mar 18 | 2 | -3 | 5 | 0 |
31 Dec 17 | 2 | -3 | 5 | 0 |
31 Dec 16 | 0 | -2 | 2 | 0 |
Quality Earnings: 9C7 is currently unprofitable.
Growing Profit Margin: 9C7 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 9C7 is unprofitable, and losses have increased over the past 5 years at a rate of 39.3% per year.
Accelerating Growth: Unable to compare 9C7's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 9C7 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).
Return on Equity
High ROE: 9C7 has a negative Return on Equity (-54.09%), as it is currently unprofitable.